Home » Newsletters » BioWorld Science

BioWorld Science

March 24, 2010

View Archived Issues

Austrian scientists claim new antidiabetic agents

CalciMedica claims new calcium release-activated calcium channel protein inhibitors

NeuroSearch identifies new monoamine reuptake inhibitors

Piramal Life Sciences presents new diacylglycerol O-acyltransferase 1 inhibitors

Novel VEGFR-2 inhibitors presented by Hutchison MediPharma

Baxter reports on Vero cell-derived influenza vaccines

Booster dose of Japanese encephalitis vaccine Ixiaro enhances immunogenicity

Pentamycin effective against bacterial vaginosis

Persistent antibody response noted in adolescents 2 years after vaccination with Men ACWY

Valnoctamide demonstrates antimanic efficacy in double-blind trial

NAVIGATOR data on cardiovascular events and diabetes in at-risk patients presented

NCI-sponsored phase I/II trial of Spectrum's belinostat initiated in thymic malignancies

CytoDyn increases funds to accelerate Cytolin trial in HIV

FDA advisory committee: insufficient trial data on pixantrone in relapsed/refractory NHL

EMA's CHMP recommends new Kepivance label in Europe

FDA and EMA respond to GSK's report on rotavirus DNA in Rotarix vaccine

BioSante reports FDA orphan drug designation and phase II data for GVAX(R) leukemia vaccine

Novel selective M1 allosteric receptor modulators disclosed at ACS meeting

Clinical Data submits vilazodone NDA for major depressive disorder to FDA

EMA completes validation of InterMune's pirfenidone MAA for IPF

FDA approves Boehringer Ingelheim's once-daily Mirapex ER for Parkinson's disease

Garnet begins dosing in phase II trial of GBT-009 for improved scar appearance

GSK obtains Swiss approval for Duodart in benign prostatic hyperplasia

Pain Therapeutics reports phase I clinical data on PTI-188 in skin cancer

Innate Immune and Cephalon Australia to collaborate to develop antibodies for asthma and SLE

Teva Pharmaceutical terminates license agreement with Antisense Therapeutics for ATL-1102

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 5, 2026.
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
Bial-Portela discovers new OX1 receptor antagonists
BioWorld Science
Bial-Portela & Ca SA has patented new orexin OX1 receptor antagonists potentially useful for the treatment of anxiety disorders, depression, eating disorders,...
FB-7033 demonstrates efficacy in MASH management
BioWorld Science
17-β-Hydroxysteroid dehydrogenase 13 (HSD17B13) and lipid transferase CIDEB are known to contribute to metabolic dysfunction-associated steatohepatitis (MASH)...
Preclinical results support Actinium’s radioconjugate ATNM‑400 for NSCLC
BioWorld Science
At the recent meeting of the Society of Nuclear Medicine and Molecular Imaging, researchers from Actinium Pharmaceuticals Inc. presented preclinical efficacy data...